Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Sigilon Therapeutics, Inc. | 0 | reported | 08 Dec 2020 | tx 6+10,370,369−10,370,369 |
| Rubius Therapeutics, Inc. | 0 | reported | 20 Jul 2018 | tx 20+33,296,526−33,296,526 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Dec 2020 | CONVERSION | Sigilon Therapeutics, Inc. | 1,481,481 | — | |
| 08 Dec 2020 | CONVERSION | Sigilon Therapeutics, Inc. | 8,888,888 | — | |
| 08 Dec 2020 | CONVERSION | Sigilon Therapeutics, Inc. | 4,074,074 | — | deriv |
| 08 Dec 2020 | CONVERSION | Sigilon Therapeutics, Inc. | 370,370 | — | deriv |
| 08 Dec 2020 | CONVERSION | Sigilon Therapeutics, Inc. | 1,481,481 | — | deriv |
| 08 Dec 2020 | CONVERSION | Sigilon Therapeutics, Inc. | 4,444,444 | — | deriv |
| 20 Jul 2018 | CONVERSION | Rubius Therapeutics, Inc. | 5,000,000 | — | |
| 20 Jul 2018 | CONVERSION | Rubius Therapeutics, Inc. | 593,948 | — | |
| 20 Jul 2018 | CONVERSION | Rubius Therapeutics, Inc. | 593,948 | — | |
| 20 Jul 2018 | CONVERSION | Rubius Therapeutics, Inc. | 1,781,843 | — | |
| 20 Jul 2018 | CONVERSION | Rubius Therapeutics, Inc. | 195,466 | — | |
| 20 Jul 2018 | CONVERSION | Rubius Therapeutics, Inc. | 781,860 | — | |
| 20 Jul 2018 | CONVERSION | Rubius Therapeutics, Inc. | 15,323,593 | — | |
| 20 Jul 2018 | CONVERSION | Rubius Therapeutics, Inc. | 3,830,402 | — | |
| 20 Jul 2018 | CONVERSION | Rubius Therapeutics, Inc. | 5,000,000 | — | |
| 20 Jul 2018 | CONVERSION | Rubius Therapeutics, Inc. | 195,466 | — | |
| 20 Jul 2018 | CONVERSION | Rubius Therapeutics, Inc. | 593,948 | — | deriv |
| 20 Jul 2018 | CONVERSION | Rubius Therapeutics, Inc. | 593,948 | — | deriv |
| 20 Jul 2018 | CONVERSION | Rubius Therapeutics, Inc. | 5,000,000 | — | deriv |
| 20 Jul 2018 | CONVERSION | Rubius Therapeutics, Inc. | 5,000,000 | — | deriv |
| 20 Jul 2018 | CONVERSION | Rubius Therapeutics, Inc. | 3,830,402 | — | deriv |
| 20 Jul 2018 | CONVERSION | Rubius Therapeutics, Inc. | 15,323,593 | — | deriv |
| 20 Jul 2018 | CONVERSION | Rubius Therapeutics, Inc. | 781,860 | — | deriv |
| 20 Jul 2018 | CONVERSION | Rubius Therapeutics, Inc. | 195,466 | — | deriv |
| 20 Jul 2018 | CONVERSION | Rubius Therapeutics, Inc. | 195,466 | — | deriv |